US researchers develop algorithm test to identify aggressive ovarian cancers
Ovarian high-grade serous carcinoma is the most common form of aggressive ovarian cancer
Read More
Tag: Repetitive Element AneupLoidy Sequencing System
- Argo Biopharma doses first patient in phase 2b trial of BW‑20829
- Akari files new patent and advances second ADC targeting CEACAM5
- BioMed X launches kidney disease project in partnership with the government of Barbados
- Gedeon Richter UK takes over UK rights to cariprazine
- Otsuka Pharmaceutical’s Dawnzera receives EC approval for hereditary angioedema prevention
